These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 30545401)

  • 21. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.
    Bibiloni R; Mangold M; Madsen KL; Fedorak RN; Tannock GW
    J Med Microbiol; 2006 Aug; 55(Pt 8):1141-1149. PubMed ID: 16849736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.
    Kabeerdoss J; Sankaran V; Pugazhendhi S; Ramakrishna BS
    BMC Gastroenterol; 2013 Jan; 13():20. PubMed ID: 23351032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity.
    Kozhieva M; Naumova N; Alikina T; Boyko A; Vlassov V; Kabilov MR
    BMC Microbiol; 2019 Dec; 19(1):309. PubMed ID: 31888483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.
    Carstens A; Dicksved J; Nelson R; Lindqvist M; Andreasson A; Bohr J; Tysk C; Talley NJ; Agréus L; Engstrand L; Halfvarson J
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00065. PubMed ID: 31343467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of blood on the human gut microbiome.
    Chénard T; Malick M; Dubé J; Massé E
    BMC Microbiol; 2020 Mar; 20(1):44. PubMed ID: 32126968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patients.
    Alatawi H; Mosli M; Saadah OI; Annese V; Al-Hindi R; Alatawy M; Al-Amrah H; Alshehri D; Bahieldin A; Edris S
    Bosn J Basic Med Sci; 2022 Jun; 22(3):412-426. PubMed ID: 34761733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
    Park Y; Ahn JB; Kim DH; Park IS; Son M; Kim JH; Ma HW; Kim SW; Cheon JH
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.
    Tani M; Shinzaki S; Asakura A; Tashiro T; Amano T; Otake-Kasamoto Y; Yoshihara T; Yoshii S; Tsujii Y; Hayashi Y; Inoue T; Motooka D; Nakamura S; Iijima H; Takehara T
    PLoS One; 2023; 18(4):e0283880. PubMed ID: 37071621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overrepresentation of Enterobacteriaceae and
    Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
    Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.
    Doherty MK; Ding T; Koumpouras C; Telesco SE; Monast C; Das A; Brodmerkel C; Schloss PD
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Origin of Plasma-Derived Bacterial Extracellular Vesicles in Healthy Individuals and Patients with Inflammatory Bowel Disease: A Pilot Study.
    Jones E; Stentz R; Telatin A; Savva GM; Booth C; Baker D; Rudder S; Knight SC; Noble A; Carding SR
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains.
    Bosselaar S; Dhelin L; Dautel E; Titecat M; Duthoy S; Stelmaszczyk M; Delory N; De Sousa Violante M; Machuron F; Ait-Abderrahim H; Desreumaux P; Foligné B; Monnet C
    BMC Microbiol; 2024 Jun; 24(1):233. PubMed ID: 38951788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients.
    Scanu M; Toto F; Petito V; Masi L; Fidaleo M; Puca P; Baldelli V; Reddel S; Vernocchi P; Pani G; Putignani L; Scaldaferri F; Del Chierico F
    Front Cell Infect Microbiol; 2024; 14():1366192. PubMed ID: 38779566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
    Maldonado-Arriaga B; Sandoval-Jiménez S; Rodríguez-Silverio J; Lizeth Alcaráz-Estrada S; Cortés-Espinosa T; Pérez-Cabeza de Vaca R; Licona-Cassani C; Gámez-Valdez JS; Shaw J; Mondragón-Terán P; Hernández-Cortez C; Suárez-Cuenca JA; Castro-Escarpulli G
    Microbiologyopen; 2021 Mar; 10(2):e1181. PubMed ID: 33970546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.
    Lin B; Wang M; Gao R; Ye Z; Yu Y; He W; Qiao N; Ma Z; Ji C; Shi C; Zhou X; Wang Y; Zeng F; Zhang L; Gong W; Cao Z; Zhou P; Melnikov V; Ye H; Li Y; Zhang Z; He M; Qin H; Zhang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0042521. PubMed ID: 35019688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.